BRANDI LAFOUNTAIN: Open Payments
NPI 1760041081 · BLANDON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 86 payments from 13 companies in 2025. Trend: 2023 $2,289 · 2024 $1,899 · 2025 $1,451
Food & beverage: $1,351Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $343 |
| Janssen Biotech, Inc. | 11 | $212 |
| Regeneron Healthcare Solutions, Inc. | 5 | $144 |
| Galderma Laboratories, L.P. | 13 | $138 |
| Lilly USA, LLC | 10 | $124 |
| UCB, Inc. | 4 | $92 |
| GENZYME CORPORATION | 3 | $88 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Organon LLC | 4 | $65 |
| LEO Pharma Inc. | 3 | $57 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, TALTZ, NEMLUVIO, Bimzelx, RINVOQ, ADBRY.
Industry payments across PA — which companies pay providers there.
